Twist Bioscience Corporation (TWST)
NASDAQ
Closed
Oct 8, 2026
Day's Range
144.6052 wk Range
23.30Overview - TWST - Twist Bioscience Corporation
Key Statistics
Valuation
Enterprise Value
11.48B
P/E (Trailing)
‪-140.79‬
P/E (Forward)
‪-290.95‬
PEG Ratio
‪0.53‬
Price / Sales (TTM)
‪28.25‬
Price / Book
‪25.87‬
EV / EBITDA
‪-99.59‬
Profitability
Gross Margin
‪52.75%‬
Profit Margin
‪-31.66%‬
Operating Margin
‪-30.64%‬
Return on Assets
‪-13.08%‬
Return on Equity
‪-29.59%‬
Ownership
Shares Outstanding
62.67M
Float
61.96M
Short % of Shares Outstanding
‪23.79%‬
Held by Insiders
‪0.77%‬
Held by Institutions
‪116.90%‬
Price stats
Beta
‪2.22‬
50-Day Avg
‪124.44‬
200-Day Avg
‪72.42‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
13 analysts
Average price target
‪$ 105.30‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TWST - Twist Bioscience Corporation
Peers - TWST - Twist Bioscience Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- TWSTNASDAQTwist Bioscience Corporation12.12BMarket Cap+85.23%52-week change-140.79P/E (Trailing)‪-31.66%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - TWST - Twist Bioscience Corporation
About
Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
